MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features"

  • 2019 International Congress

    Non-motor Symptoms in Hyperkinetic Movement Disorders

    H. Egit, M. Balal, M. Demirkiran (Adana, Turkey)

    Objective: To evaluate the frequencies and clinical features of non-motor symptoms in several different hyperkinetic movement disorders and compare them with the healthy age- and…
  • 2018 International Congress

    Investigating the clinical predictors of depression in Huntington’s disease: An Enroll-HD Database Study

    E. Furr Stimming, G. Colpo, N. Rocha, A. Teixeira (Houston, TX, USA)

    Objective: This study was designed to investigate clinical predictors of depression in subjects with HD. Background: Huntington’s disease (HD) is characterized by motor, cognitive and…
  • 2018 International Congress

    Crack Dancing: An Uncommon Drug-Induced Chorea

    G. Gibb, D. Nacopoulos (Erie, PA, USA)

    Objective: To report a unique case of cocaine induced choreiform dyskinetic movements with literature review of this condition. Background: Various abnormal movements have been known…
  • 2018 International Congress

    Driving performance of Huntington’s disease gene carriers

    M. Jacobs, E. Hart, Y. Mejia Miranda, G.J. Groeneveld, J. van Gerven, R. Roos (Leiden, Netherlands)

    Objective: To investigate if differences in driving performance between Huntington's disease (HD) gene carriers and healthy individuals can be detected with a driving simulator. Furthermore,…
  • 2018 International Congress

    Education in hyperkinetic movement disorders in Cameroonian health providers

    M.H.G. Monje, M.M. Kurtis, M. Molina, C. Delgado-Suárez, P. Gómez-Iglesias, I. García-Morales, D. García-Azorín (Móstoles, Madrid, Spain)

    Objective: To evaluate the educational gaps in hyperkinetic movement disorders among a widely-varied sample of Cameroonian health providers and improve understanding through a practical training…
  • 2018 International Congress

    Malignant gliomas in patients with Huntington’s disease

    S. Chandra, G. Suarez-Cedeno, E. Stimming (Houston, TX, USA)

    Objective: Discuss the presentation of glioblastoma multiforme in patients with Huntington’s disease Background: Huntington’s disease (HD) is an inherited neurodegenerative disorder caused by a trinucleotide…
  • 2018 International Congress

    The History of Huntington Disease Description in Russia

    D. Labunskiy (Santa Rosa, CA, USA)

    Objective: The report provides detailed material on the history of the description of Huntington's disease (HD) in Russia. The first, unknown to a wide audience,…
  • 2018 International Congress

    Assessing the potential of EEG as a biomarker in Huntington’s disease using machine learning automatic classification

    O. Odish, K. Johnsen, P. van Someren, R. Roos, G. van Dijk (Leiden, Netherlands)

    Objective: To construct an automatic classifier distinguishing healthy controls from Huntington’s disease (HD) gene carriers using quantitative electroencephalography (qEEG) and to derive qEEG features that…
  • 2018 International Congress

    Generalized choreoathetoid-like movements in primary Sjögren syndrome

    N. Alvarado-Franco, L. Olguín-Ramírez, A. Garza-Alpirez, G. Femat-Roldan, D. Martinez-Ramirez (Monterrey, Mexico)

    Objective: To report a case of choreoathetoid-like movements associated to primary Sjögren syndrome. Background: Autoimmune diseases are not uncommon causes of movement disorders. Two percent…
  • 2018 International Congress

    Late onset Huntington’s disease in an Argentinian cohort

    M. Cesarini, J. Etcheverry, E. Gatto, J. Ziliani, G. Da Prat, N. Gonzalez Rojas, V. Parisi, G. Persi (Buenos Aires, Argentina)

    Objective: To describe the prevalence, clinical and molecular characteristics of a series of LOHD patients in an Argentinean cohort. Background: Late onset Huntington’s disease (LOHD)…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley